Actinium Pharmaceuticals
ATNM
$8.84
Share price
-1.34%
Change (1 day)
2.20%
Change (1 year)
Categories
Earnings for Actinium Pharmaceuticals (ATNM)
Earnings in 2023 (TTM): -$51.92 M
According to Actinium Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$49.94 M. a decrease over its 2022 earnings that were of -$34.11 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Actinium Pharmaceuticals from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$51.92 M | 52.24% |
| 2022 | -$34.11 M | 36.61% |
| 2021 | -$24.97 M | 11.48% |
| 2020 | -$22.4 M | 1.46% |
| 2019 | -$22.08 M | -7.37% |
| 2018 | -$23.83 M | -11.46% |
| 2017 | -$26.92 M | 10.67% |
| 2016 | -$24.32 M | 15.7% |
| 2015 | -$21.02 M | -14.86% |
| 2014 | -$24.69 M | 129.19% |
| 2013 | -$10.78 M | -8.55% |
| 2012 | -$11.78 M | |
| 2010 | $0 M | -152.15% |
| 2009 | -$0.02 M | -39.8% |
| 2008 | -$0.03 M | 120.29% |
| 2007 | -$0.02 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | -$37.2 M | -25.52% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.16 B | 200.60% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.23 B | -575.34% | 🇺🇸 USA |